April 20, 2021
Over the past three years, Genmab has retained The Chase Group to execute four Director, Drug Safety and Pharmacovigilance (PV) physician searches that all concluded with a successful placement. Genmab, currently on a trajectory of rapid growth, has once again “cut to The Chase” as they prepare to expand their leadership team to include a Senior Director/Team Lead, Global Drug Safety and PV physician. This new role will report to the Vice President/Head of Global Drug Safety & PV and serve as the safety expert accountable for the global safety strategy and overall safety profile for assigned Genmab products throughout their lifecycle. Genmab’s commitment to bringing new medicines to the market to improve patients’ lives is a strong motivation for The Chase Group to identify and secure executive leaders who embody Genmab’s culture of excellence and innovation as they work to pioneer the next generation of antibody platforms. To learn more, email ken@chasegroup.com.
